Alnylam Pharmaceuticals, Inc.
2020 Q2 - 2025 Q4 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/8/2026 | 5,740 | 0.0% | 14,087 | 12/31/2025 |
| 2025 Q3 | 10/29/2025 | 6,675 | 0.0% | 14,525 | 9/30/2025 |
| 2025 Q2 | 7/10/2025 | 1,699 | 0.0% | 5,118 | 6/30/2025 |
| 2025 Q1 | 4/16/2025 | 3,889 | 0.0% | 14,404 | 3/31/2025 |
| 2024 Q4 | 3/17/2025 | 2,957 | 0.0% | 12,566 | 12/31/2024 |
| 2024 Q3 | 10/24/2024 | 1,775 | 0.0% | 6,454 | 9/30/2024 |
| 2024 Q2 | 7/16/2024 | 1,004 | 0.0% | 4,131 | 6/30/2024 |
| 2024 Q1 | 4/15/2024 | 440 | 0.0% | 2,947 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 459 | 0.0% | 2,399 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 387 | 0.0% | 2,183 | 9/30/2023 |
| 2020 Q2 | 10/13/2020 | 1,384 | 0.0% | 8,758 | 6/30/2020 |